Leveragen

Leveragen Partners with Daiichi Sankyo – In Vivo Antibody Discovery Collaboration Targets Advanced Biologics

Leveragen, a Boston-based biotechnology company developing next-generation in vivo platforms for antibody discovery, announced a...